Nanomaterial-Based Agents for Bacterial Infection Detection and Treatment
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Applied Chemistry".
Deadline for manuscript submissions: closed (15 April 2022) | Viewed by 262
Special Issue Editor
Interests: multi-functional antimicrobial biomaterials; antibacterial; antibiotics; nanomedicine; infectious disease; drug-resistant
Special Issue Information
Dear Colleagues,
Infectious diseases, for example, suppurative wound infection and systemic infection, have been a major threat to human health for decades. Currently, antibiotics are still the best choice in clinical practice. Nevertheless, clinicians often prescribe antibiotics without identifying the pathogen, which exacerbates the emergence of antibiotic-resistant strains, especially during the COVID-19 pandemic, causing antibiotics' therapeutic efficacy to decrease. To alleviate the development of drug resistance and extend the lifetime of antibiotics, the development of rapid and comprehensive bacterial detection methods is critical for precision medication. In addition, expanding the antibacterial arsenal is highly desirable. Recently, benefiting from the advances in nanotechnology, nanomaterials have exhibited huge potential in improving antimicrobial efficacy and preventing drug resistance. Therefore, the nanoplatform, which integrates detection and antibacterial performance, is a new and valuable treatment strategy for the treatment of bacterial infections.
The aim of this Special Issue of Molecules is to collect research and review manuscripts in the fields of the development of novel nanoprobes and nano therapeutic agents (organic and inorganic) for the diagnosis and treatment of infectious diseases. We welcome the submission of both research and review manuscripts to be published in this Special Issue.
Dr. Dongliang Yang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bacterial
- infectious disease
- detection
- diagnosis
- antibacterial
- nanomedicine
